8-KThe WireRoutine
Bylaw Amendment
Filed Feb 24, 2023 · 3y ago · Accession 0001437749-23-004450
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- ZEVRA THERAPEUTICS, INC.
- Ticker
- ZVRA
- CIK
- 1434647
- Form type
- 8-K
- Filing date
- Feb 24, 2023
- Report date
- Feb 21, 2023
- Document
- kmph20230220_8k.htm
- Size
- 342 KB